BioCentury
ARTICLE | Financial News

Akriveia raises $7.5M in series A

October 12, 2016 7:00 AM UTC

Immuno-oncology newco Akriveia Therapeutics Inc. (Thousand Oaks, Calif.) said it raised $7.5 million in a series A round from sole investor F-Prime Capital Partners.

Akriveia is developing cancer immunotherapies that are activated within the tumor microenvironment, which it says can reduce side effects and increase the therapies' utility. The company has licensing agreements covering the platform with City of Hope and Thomas Jefferson University. ...